Veru VERU
NASDAQ VERU
$2.56 +0.03 (+1.39%)
At close: Sep 29, 2026 · 4:00 PM EDT

Veru (VERU) Share-based Compensation (2010 - 2026)

Updated

Veru (VERU) reported Share-based Compensation of $577,969 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 65.4% from $1.67 million a year earlier but up 43.5% from the prior quarter.

Analysis

Veru (VERU) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Veru's Share-based Compensation came in at $3.27 million, down 66.6% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $8.1 million, down 40.6% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 25.1% (FY2020 to FY2025).
  • By fiscal year, Share-based Compensation came in at $13.64 million in FY2024 (-23.9%), $17.92 million in FY2023 (+59.4%), $11.24 million in FY2022 (+122.6%) and $5.05 million in FY2021 (+90.9%).
  • Five-year quarterly Share-based Compensation spans a low of $402,712 in fiscal Q2 2026 and a high of $4.85 million in fiscal Q1 2023.
  • Year over year, Share-based Compensation has now declined in each of the last 11 quarters, with an average decline of 51.7% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was fiscal Q4 2022 (growth of 217.5%); the low point was fiscal Q2 2026 (a decline of 81.9%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $402,712 (Q2 2026), $757,605 (Q1 2026) and $1.53 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Veru 58.32 Mn -51.96 Mn - 577,969.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 577,969.00
Mar 31, 2026 402,712.00
Dec 31, 2025 757,605.00
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.67 Mn
Mar 31, 2025 2.22 Mn
Dec 31, 2024 2.67 Mn
Sep 30, 2024 3.23 Mn
Jun 30, 2024 3.38 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 3.41 Mn
Sep 30, 2023 4.68 Mn
Jun 30, 2023 4.55 Mn
Mar 31, 2023 3.84 Mn
Dec 31, 2022 4.85 Mn
Sep 30, 2022 4.33 Mn
Jun 30, 2022 2.91 Mn
Mar 31, 2022 2.12 Mn
Dec 31, 2021 1.88 Mn
Sep 30, 2021 1.36 Mn
API Access

Veru Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VERU&period=max&api_key=YOUR_API_KEY